---
category: news
title: "Median Technologies: iBiopsy®: Promising Results on a Preliminary Study to Evaluate the Risk of Tumor Recurrence in Patients With Primary Liver Cancer"
excerpt: "Median Technologies (Paris:ALMDT) (ALMDT), The Imaging Phenomics Company®, announces today the results of a preliminary retrospective study on the evaluation of the risk of recurrence for patients with primary liver cancer (HCC – hepatocellular carcinoma) based on a non-invasive biomarker."
publishedDateTime: 2020-06-17T15:45:00Z
webUrl: "https://www.businesswire.com/news/home/20200617005460/en/Median-Technologies-iBiopsy®-Promising-Results-Preliminary-Study"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://mms.businesswire.com/media/20200617005460/en/579686/23/Median_CMYK_tagline.jpg"
    width: 1200
    height: 627
    isCached: true
    title: "Median Technologies: iBiopsy®: Promising Results on a Preliminary Study to Evaluate the Risk of Tumor Recurrence in Patients With Primary Liver Cancer"

secured: "QbMrh9UtAWNgTdYSzXPZ3pT0IZV4MWkPTlKRGkqWxGVQJjmBfvgROXnrN9RxvJk2LAIAeAJv54FvjHpJ/2FECWEjFCFNXo1TrbJzdUpEtpw83vZ76/R9VuQS7+9nvq2TbaiEwaOAbkajnUl876OLOeVDJW7tHtA/mxAz8e9RBj8YuJxypCFj5iZxdNx465trM+xPo2Yz9exMeWgm86p3qt5mY7YHhhCG1gjjoFCflyaefcfiuIOOEk/qCELi9PpbEzmbDLpGLhBydEGMixBYkgW4P3ZWBFjMX3+RQEeIrkWuNl/li1XywfOTEPf6kHWbCVAAEE1K518Wejp0aDdd/w==;tpU7iCClU5a6Yu/ldWnDlA=="
---

